Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers

Press/Media: Press / Media

Period2018 Oct 2 → 2020 Oct 28

Media coverage

2

Media coverage